Cellular leiomyoma: A 10‐year retrospective analysis of clinical features, and recurrence risk
Journal of Obstetrics and Gynaecology Research · 2025
DOI: 10.1111/jog.16359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2025. Verfasst von Yang Ming und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Leiomyoma, Uterine Neoplasms, Neoplasm Recurrence, Local, Uterine Myomectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Young and Middle-aged Medical Talents Training Project of Wuhan, the Natural Science Foundation of Hubei Province of China.
Abstract (Originalsprache)
Objectives
In this study, we aimed to compare the clinical characteristics of cellular leiomyoma (CL) with those of typical uterine leiomyoma (UL) and explore recurrence risk factors in patients with CL myomectomy. Study Design In this retrospective cohort study, we analyzed medical records of patients diagnosed with CL ( n = 102) and UL ( n = 105) who underwent surgery between January 2013 and May 2023. Postoperative prognosis was assessed through patient follow‐up until June 2024.
Results
Patients with CL were likelier to have adenomyosis (odds ratio [OR], 4.06; 95% confidence interval [CI], 1.28–12.88; p = 0.017) and late‐age menarche (OR, 1.50; 95% CI, 1.15–1.95; p = 0.002). A uterus that has three or fewer fibroids (OR, 2.14; 95% CI, 1.05–4.37; p = 0.037) was more likely to develop into CL than the control group. Concerning the predictive aspect, more than three fibroids are associated with a higher risk of recurrence (OR, 5.33; 95% CI, 1.02–27.76; p = 0.047). The use of hysteroscopy to remove submucosal fibroids is associated with a lower risk (OR, 0.08; 95% CI, 0.01–0.78; p = 0.030).
Conclusions
This study confirms that CL exhibits distinct clinical characteristics from ULs, with a higher postoperative recurrence rate and risks of malignant transformation and abdominal dissemination. Our study identified for the first time that adenomyosis is an independent risk factor for CL. Additionally, submucous fibroids tend to be resected while still small, allowing for more complete removal and reducing recurrence risk. An increased number of fibroids was also identified as a risk factor for recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China.
- Department of Gynecology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of School of Basic Medicine, Hubei University of Arts and Science, Xiangyang, Hubei, China.
- Department of Traditional Chinese Medicine, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
ORCID-Profile: Tongfu Feng
Förderung
- Young and Middle-aged Medical Talents Training Project of Wuhan
- the Natural Science Foundation of Hubei Province of China
Zitieren
APA
Ming, Y., Liang, T., Wang, L., Jiang, D., & Feng, T. (2025). Cellular leiomyoma: A 10‐year retrospective analysis of clinical features, and recurrence risk. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16359
Vancouver
Ming Y, Liang T, Wang L, Jiang D, Feng T. Cellular leiomyoma: A 10‐year retrospective analysis of clinical features, and recurrence risk. Journal of Obstetrics and Gynaecology Research. 2025. doi:10.1111/jog.16359
BibTeX
@article{Ming2025,
author = {Ming, Yang and Liang, Ting and Wang, Lu and Jiang, Duosheng and Feng, Tongfu},
title = {Cellular leiomyoma: A 10‐year retrospective analysis of clinical features, and recurrence risk},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
doi = {10.1111/jog.16359}
}
EUVIMED